Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.30
Delayed Data
As of 3:31pm ET
 -0.1001 / -4.17%
Today’s Change
1.93
Today|||52-Week Range
4.70
+0.56%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close2.40
Today’s open2.26
Day’s range2.23 - 2.39
Volume10,729
Average volume (3 months)6,283
Market cap$12.3M
Data as of 3:31pm ET, 01/22/2018

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.45

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc+0.01+4.12%
CYANCyanotech Corp+0.01+0.13%
IBIOIbio Inc+0.00+2.04%
ISRIsoRay Inc+0.02+4.11%
Data as of 4:10pm ET, 01/22/2018

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts